Letter: The control of aldosterone in anephric man. 1975

J Deheneffe, and V Cuesta, and I Robertson

UI MeSH Term Description Entries
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D005082 Physical Exertion Expenditure of energy during PHYSICAL ACTIVITY. Intensity of exertion may be measured by rate of OXYGEN CONSUMPTION; HEAT produced, or HEART RATE. Perceived exertion, a psychological measure of exertion, is included. Physical Effort,Effort, Physical,Efforts, Physical,Exertion, Physical,Exertions, Physical,Physical Efforts,Physical Exertions
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000324 Adrenocorticotropic Hormone An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP). ACTH,Adrenocorticotropin,Corticotropin,1-39 ACTH,ACTH (1-39),Adrenocorticotrophic Hormone,Corticotrophin,Corticotrophin (1-39),Corticotropin (1-39),Hormone, Adrenocorticotrophic,Hormone, Adrenocorticotropic
D000450 Aldosterone A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. Aldosterone, (+-)-Isomer,Aldosterone, (11 beta,17 alpha)-Isomer
D000804 Angiotensin II An octapeptide that is a potent but labile vasoconstrictor. It is produced from angiotensin I after the removal of two amino acids at the C-terminal by ANGIOTENSIN CONVERTING ENZYME. The amino acid in position 5 varies in different species. To block VASOCONSTRICTION and HYPERTENSION effect of angiotensin II, patients are often treated with ACE INHIBITORS or with ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS. Angiotensin II, Ile(5)-,Angiotensin II, Val(5)-,5-L-Isoleucine Angiotensin II,ANG-(1-8)Octapeptide,Angiotensin II, Isoleucine(5)-,Angiotensin II, Valine(5)-,Angiotensin-(1-8) Octapeptide,Isoleucine(5)-Angiotensin,Isoleucyl(5)-Angiotensin II,Valyl(5)-Angiotensin II,5 L Isoleucine Angiotensin II,Angiotensin II, 5-L-Isoleucine

Related Publications

J Deheneffe, and V Cuesta, and I Robertson
January 1976, Acta clinica Belgica,
J Deheneffe, and V Cuesta, and I Robertson
October 1974, Clinical endocrinology,
J Deheneffe, and V Cuesta, and I Robertson
January 1973, Kidney international,
J Deheneffe, and V Cuesta, and I Robertson
August 1971, The Journal of clinical investigation,
J Deheneffe, and V Cuesta, and I Robertson
October 1973, Kidney international,
J Deheneffe, and V Cuesta, and I Robertson
January 1974, Journal d'urologie et de nephrologie,
J Deheneffe, and V Cuesta, and I Robertson
January 1973, Transactions - American Society for Artificial Internal Organs,
J Deheneffe, and V Cuesta, and I Robertson
January 1972, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association,
J Deheneffe, and V Cuesta, and I Robertson
February 1978, The Journal of clinical endocrinology and metabolism,
J Deheneffe, and V Cuesta, and I Robertson
October 1973, Kidney international,
Copied contents to your clipboard!